Neurological Research Company Updates Presentation For Autism Treatments

In an era where medical advancements are transforming lives, PaxMedica stands at the forefront of neurological research, particularly in the realm of Autism Spectrum Disorder (ASD). The biopharmaceutical company has recently updated its company presentation, highlighting its innovative approaches and breakthroughs in ASD treatments. $PaxMedica(PXMD.US)$